Basic Information | |
---|---|
Species | Glycine max |
Cazyme ID | Glyma17g11840.2 |
Family | GT47 |
Protein Properties | Length: 471 Molecular Weight: 54437.5 Isoelectric Point: 9.7232 |
Chromosome | Chromosome/Scaffold: 17 Start: 8893843 End: 8896348 |
Description | Exostosin family protein |
View CDS |
External Links |
---|
NCBI Taxonomy |
Plaza |
CAZyDB |
Signature Domain Download full data set without filtering | |||
---|---|---|---|
Family | Start | End | Evalue |
GT47 | 133 | 419 | 0 |
KRFKVWVYEEGEQPLVHYGPVNDIYAIEGQFIDEIDNSKRSPFKARNPDEAHAFFLPLSVVNVVHYVYKPYMSQNDYSRDRLQRLVEDYIGVVADKYPYW NRSNGADHFLLSCHDWAPEISHANPDLFKNFIRVLCNANNSEGFQPKRDVSIPEVYLPVGKLGPPNLGQHPMNRTILAFFSGGAHGDIRKLLLKHWKDKD NHVQVHEYLPKGQNYTELMGLSKFCLCPSGYEVASPRVVEAINAGCVPVIISENYSLPFSDVLNWSQFSIQISVENISDIKTILQNV |
Full Sequence |
---|
Protein Sequence Length: 471 Download |
MLYSRCSTAS MLLPLLFSIF LFLFIIHLKG NQHLSFEFPN FSLSSIKGIT TQLLRPHGQY 60 LANSAYRSLE HRSKKRTSFD VVEEGLAKAR ASIREAILYR NHSNSGKQEH FIPKGSIYRN 120 PHAFHQSHME MVKRFKVWVY EEGEQPLVHY GPVNDIYAIE GQFIDEIDNS KRSPFKARNP 180 DEAHAFFLPL SVVNVVHYVY KPYMSQNDYS RDRLQRLVED YIGVVADKYP YWNRSNGADH 240 FLLSCHDWAP EISHANPDLF KNFIRVLCNA NNSEGFQPKR DVSIPEVYLP VGKLGPPNLG 300 QHPMNRTILA FFSGGAHGDI RKLLLKHWKD KDNHVQVHEY LPKGQNYTEL MGLSKFCLCP 360 SGYEVASPRV VEAINAGCVP VIISENYSLP FSDVLNWSQF SIQISVENIS DIKTILQNVT 420 QKKYKKLHRN VRRVQRHFVM NRPAKPFDLM HMILHSIWLR RLNFRVMASH * 480 |
Functional Domains Download unfiltered results here | ||||||||
---|---|---|---|---|---|---|---|---|
Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
pfam03016 | Exostosin | 4.0e-68 | 131 | 419 | 307 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. |
Gene Ontology | |
---|---|
GO Term | Description |
GO:0016020 | membrane |
Annotations - NR Download unfiltered results here | |||||||
---|---|---|---|---|---|---|---|
Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
GenBank | ABP03872.1 | 0 | 74 | 466 | 74 | 465 | Exostosin-like [Medicago truncatula] |
GenBank | ABP03873.1 | 0 | 42 | 469 | 193 | 616 | Exostosin-like [Medicago truncatula] |
EMBL | CBI21065.1 | 0 | 74 | 466 | 10 | 400 | unnamed protein product [Vitis vinifera] |
EMBL | CBI25537.1 | 0 | 74 | 464 | 83 | 473 | unnamed protein product [Vitis vinifera] |
RefSeq | XP_002263848.1 | 0 | 74 | 464 | 2 | 392 | PREDICTED: hypothetical protein [Vitis vinifera] |
Metabolic Pathways | |||
---|---|---|---|
Pathway Name | Reaction | EC | Protein Name |
xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |